Management of schizophrenia in women during the perinatal period: a synthesis of international recommendations

References

• Jones I, Chandra PS, Dazzan P, et al. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet. 2014;384(9956):1789–1799.
   PubMed Web of Science ®Google Scholar
• Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. the eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118 Suppl 1:1–203.
   PubMedGoogle Scholar
• Khalifeh H, Hunt IM, Appleby L, et al. Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry. Lancet Psychiatry. 2016;3(3):233–242.
   PubMed Web of Science ®Google Scholar
• Caqueo-Urizar A, Rus-Calafell M, Craig TK, et al. Schizophrenia: impact on family dynamics. Curr Psychiatry Rep. 2017;19(1):2.
   PubMedGoogle Scholar
• Forcheron V, Sacareau E, and Bourgeois J, et al. Experience, impact and needs of informal parental caregivers around the communication of a diagnosis of schizophrenia. Int J Soc Psychiatry. 2022 Jan 6;207640211068978.
   Google Scholar
• Donde C, Vignaud P, Poulet E, et al. Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines. Acta Psychiatr Scand. 2018;138(4):289–299.
   PubMedGoogle Scholar
• Gaebel W, Weinmann S, Sartorius N, et al. Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry. 2005;187(3):248–255.
   PubMedGoogle Scholar
• Keating D, McWilliams S, Schneider I, et al. Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode. BMJ Open. 2017;7(1):e013881.
   PubMed Web of Science ®Google Scholar
• Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410–472.
   PubMed Web of Science ®Google Scholar
• Keepers GA, Fochtmann LJ, Anzia JM, et al. The American psychiatric association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–872.
   PubMed Web of Science ®Google Scholar
• Remington G, Addington D, Honer W, et al. Guidelines for the pharmacotherapy of schizophrenia in adults. Can J Psychiatry. 2017;62(9):604–616.
   PubMed Web of Science ®Google Scholar
• Phahladira L, Luckhoff HK, Asmal L, et al. Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders. NPJ Schizophr. 2020;6(1):2.
   PubMed Web of Science ®Google Scholar
• Schennach R, Obermeier M, Spellmann I, et al. Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression. Schizophr Res. 2019;209:185–192.
   PubMedGoogle Scholar
• Case M, Stauffer VL, Ascher-Svanum H, et al. The heterogeneity of antipsychotic response in the treatment of schizophrenia. Psychol Med. 2011;41(6):1291–1300.
   PubMedGoogle Scholar
• McCutcheon RA, Pillinger T, Efthimiou O, et al. Reappraising treatment effect heterogeneity in schizophrenia: a meta-analysis. medRxiv - Psychiatry Clin Psychol (IF). 2021.
   Google Scholar
• Mayston R, Kebede D, Fekadu A, et al. The effect of gender on the long-term course and outcome of schizophrenia in rural Ethiopia: a population-based cohort. Soc Psychiatry Psychiatr Epidemiol. 2020;55(12):1581–1591.
   PubMedGoogle Scholar
• Sommer IE, Tiihonen J, van Mourik A, et al. The clinical course of schizophrenia in women and men-a nation-wide cohort study. NPJ Schizophr. 2020;6(1):12.
   PubMedGoogle Scholar
• Seeman MV. Men and women respond differently to antipsychotic drugs. Neuropharmacology. 2020;163:107631.
   PubMed Web of Science ®Google Scholar
• Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86–97.
   PubMed Web of Science ®Google Scholar
• Brand BA, Haveman YRA, and de Beer F, et al. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol Med. 2021Nov 12;52(4):1–15.
   Google Scholar
• Vigod SN, Seeman MV, Ray JG, et al. Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996-2009): a population-based study in Ontario, Canada. Schizophr Res. 2012;139(1–3):169–175.
   PubMed Web of Science ®Google Scholar
• Fabre C, Pauly V, Baumstarck K, et al. Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study. Lancet Reg Health Eur. 2021;10:100209.
   PubMedGoogle Scholar
• Jablensky AV, Morgan V, Zubrick SR, et al. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162(1):79–91.
   PubMed Web of Science ®Google Scholar
• Miller LJ, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv. 1996;47(5):502–506.
   PubMed Web of Science ®Google Scholar
• Solari H, Dickson KE, Miller L. Understanding and treating women with schizophrenia during pregnancy and postpartum–Motherisk update 2008. Can J Clin Pharmacol. 2009;16(1):e23–32.
   PubMedGoogle Scholar
• Rochon-Terry G, Gruneir A, Seeman MV, et al. Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia. J Clin Psychiatry. 2016;77(4):541–547.
   PubMedGoogle Scholar
• Wesseloo R, Kamperman AM, Munk-Olsen T, et al. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016;173(2):117–127.
   PubMed Web of Science ®Google Scholar
• Betcher HK, Montiel C, Clark CT. Use of antipsychotic drugs during pregnancy. Curr Treat Options Psychiatry. 2019;6(1):17–31.
   PubMedGoogle Scholar
• Kulkarni J, Storch A, Baraniuk A, et al. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16(9):1335–1345.
   PubMed Web of Science ®Google Scholar
• Andrade C. Gestational and neurodevelopmental outcomes associated with antipsychotic drug exposure during pregnancy. J Clin Psychiatry. 2021 Oct 12;82(5):21f14265.
   Google Scholar
• Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol. 2015;116(4):315–320.
   PubMed Web of Science ®Google Scholar
• Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36(3):518–544.
   PubMed Web of Science ®Google Scholar
• Terrana N, Koren G, Pivovarov J, et al. Pregnancy outcomes following in utero exposure to second-generation antipsychotics: a systematic review and meta-analysis. J Clin Psychopharmacol. 2015;35(5):559–565.
   PubMed Web of Science ®Google Scholar
• Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand. 2013;127(1):12–22.
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Belzeaux R, Sanguinetti C, Murru A, et al. Pharmacotherapy for the peripartum management of bipolar disorder. Expert Opin Pharmacother. 2019;20(14):1731–1741.
   PubMed Web of Science ®Google Scholar
• Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–842.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association Editor. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. 3rd ed. Washington DC: American Psychiatric Association; 2021. Ed.^(Eds)
   Google Scholar
• Barnes TR, Drake R, Paton C, et al. Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British association for psychopharmacology. J Psychopharmacol. 2020;34(1):3–78.
   PubMed Web of Science ®Google Scholar
• Ministry Of Health Malaysia. Ministry of health clinical practice guidelines: management of schizophrenia in adults. 2009. https://www.moh.gov.my/moh/attachments/3882.pdf. Ed.^(Eds)
   Google Scholar
• National Clinical Guideline Centre. NICE. Antenatal and postnatal mental health: clinical management and service guidance. In: (National Clinical Guideline Number 192). 2018. https://www.nice.org.uk/guidance/cg192/evidence/full-guideline-pdf-4840896925. Ed.^(Eds)
   Google Scholar
• Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland. Management of schizophrenia: a national clinical guideline. 2013.
   Google Scholar
• Hasan A, Falkai P, Wobrock T, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16(3):142–170.
   PubMed Web of Science ®Google Scholar
• Taylor CL, Broadbent M, Khondoker M, et al. Predictors of severe relapse in pregnant women with psychotic or bipolar disorders. J Psychiatr Res. 2018;104:100–107.
   PubMed Web of Science ®Google Scholar
• Seki R, Hashimoto T, Tanaka M, et al. Relapse of psychiatric symptoms after discontinuation of antipsychotics in pregnant women with schizophrenia: a retrospective study. Clin Neuropsychopharmacol Ther. 2020;11:61–66.
   Google Scholar
• Tosato S, Albert U, Tomassi S, et al. A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects. J Clin Psychiatry. 2017;78(5):e477–e489.
   PubMed Web of Science ®Google Scholar
• Galbally M, Snellen M, Power J. Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf. 2014;5(2):100–109.
   PubMedGoogle Scholar
• Huybrechts KF, Hernandez-Diaz S, and Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73(9):938–946.
   PubMed Web of Science ®Google Scholar
• McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):444–449; quiz 546.
   PubMed Web of Science ®Google Scholar
• Viguera AC, Freeman MP, Goez-Mogollon L, et al. Reproductive safety of second-generation antipsychotics: updated data from the Massachusetts general hospital national pregnancy registry for atypical antipsychotics. J Clin Psychiatry. 2021;82(4). DOI:https://doi.org/10.4088/JCP.20m13745.
   Web of Science ®Google Scholar
• Vigod SN, Gomes T, Wilton AS, et al. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ. 2015;350(may11 5):h2298.
   PubMed Web of Science ®Google Scholar
• Beex-Oosterhuis MM, Samb A, Heerdink ER, et al. Safety of clozapine use during pregnancy: analysis of international pharmacovigilance data. Pharmacoepidemiol Drug Saf. 2020;29(6):725–735.
   PubMedGoogle Scholar
• Petersen I, McCrea RL, Sammon CJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1–176.
   PubMed Web of Science ®Google Scholar
• Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord. 2018;228:229–237.
   PubMed Web of Science ®Google Scholar
• Reinstein SA, Cosgrove J, and Malekshahi T, et al. Long-acting injectable antipsychotic use during pregnancy: a brief review and concise guide for clinicians. J Clin Psychiatry. 2020;81(6). DOI:https://doi.org/10.4088/JCP.20ac13597
   Google Scholar
• Lin HC, Chen IJ, Chen YH, et al. Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res. 2010;116(1):55–60.
   PubMed Web of Science ®Google Scholar
• Damkier P, Videbech P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs. 2018;32(4):351–366.
   PubMed Web of Science ®Google Scholar
• Uguz F. A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther. 2021;28(1):e118–e126.
   PubMedGoogle Scholar
• Zincir SB. Schizophrenia and related psychoses. In: Perinatal psychopharmacology. Cham:Springer; 2019. p. 259–269.
   Google Scholar
• Brunner E, Falk DM, Jones M, et al. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol. 2013;14(1):38.
   PubMed Web of Science ®Google Scholar
• Sachs HC, Committee On D, Galinkin JL. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132(3):e796–809.
   PubMed Web of Science ®Google Scholar
• Graham RK, Tavella G, Parker GB. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? J Affect Disord. 2018;228:216–221.
   PubMed Web of Science ®Google Scholar
• Carrotte ER, Hartup ME, Lee-Bates B, et al. I think that everybody should be involved”: what informs experiences of shared decision-making in supporting people living with schizophrenia spectrum disorders? Patient Educ Couns. 2021;104(7):1583–1590.
   PubMedGoogle Scholar
• Fiorillo A, Barlati S, Bellomo A, et al. The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review. Ann Gen Psychiatry. 2020;19(1):43.
   PubMed Web of Science ®Google Scholar
• Hamann J, Langer B, Winkler V, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand. 2006;114(4):265–273.
   PubMed Web of Science ®Google Scholar
• Tuckett D. Meeting between experts: an approach to sharing ideas in medical consultations. New York: Routledge; 1986.
   Google Scholar
• Molyneaux E, Turner A, Candy B, et al. Crisis-planning interventions for people with psychotic illness or bipolar disorder: systematic review and meta-analyses. BJPsych Open. 2019;5(4):e53.
   PubMed Web of Science ®Google Scholar
• Zelle H, Kemp K, and Bonnie RJ. Advance directives in mental health care: evidence, challenges and promise. World Psychiatry. 2015;14(3):278–280.
   PubMedGoogle Scholar
• Tinland A, Loubiere S, and Mougeot F, et al. Effect of psychiatric advance directives facilitated by peer workers on compulsory admission among people with mental illness: a randomized clinical trial. JAMA Psychiatry. 2022. DOI:https://doi.org/10.1001/jamapsychiatry.2022.1627.
   Google Scholar
• Toufeili A, Cohen E, Ray JG, et al. Complex chronic conditions among children born to women with schizophrenia. Schizophr Res. 2022;241:24–35.
   PubMedGoogle Scholar
• Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1–02):e1.
   PubMed Web of Science ®Google Scholar
• Acosta FJ, Hernandez JL, Pereira J, et al. Medication adherence in schizophrenia. World J Psychiatry. 2012;2(5):74–82.
   PubMedGoogle Scholar
• El Abdellati K, De Picker L, Morrens M. Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis. Front Neurosci. 2020;14:531763.
   PubMedGoogle Scholar
• Pastol J, Le Marois M, Guilhaumou R, et al. Measuring drug concentrations in breast milk to improve therapeutic monitoring and patient adherence in bipolar disorder: a case report. Aust N Z J Psychiatry. 2022;56(1):96.
   PubMedGoogle Scholar
• Pennestri MH, Laganiere C, Bouvette-Turcot AA, et al. Uninterrupted infant sleep, development, and maternal mood. Pediatrics. 2018;142(6). DOI:https://doi.org/10.1542/peds.2017-4330.
   Google Scholar
• Moon RY. Task force on sudden infant death s. sids and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics. 2016 Nov;138(5):e20162940.
   Google Scholar
• Kaskie RE, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep. 2017;9:227–239.
   PubMed Web of Science ®Google Scholar
• Donde C, Jaffiol A, and Khouri C, et al. Sleep disturbances in early clinical stages of psychotic and bipolar disorders: a meta-analysis. Aust N Z J Psychiatry. 2021;48674211068395:1-12.
   Google Scholar
• Seedat S. Paternal perinatal mental disorders are inextricably linked to maternal and child morbidity. World Psychiatry. 2020;19(3):337–338.
   PubMedGoogle Scholar
• Bridges JF, Slawik L, Schmeding A, et al. A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia. Health Expect. 2013;16(2):164–176.
   PubMed Web of Science ®Google Scholar
• Halfdanarson O, Zoega H, Aagaard L, et al. International trends in antipsychotic use: a study in 16 countries, 2005-2014. Eur Neuropsychopharmacol. 2017;27(10):1064–1076.
   PubMed Web of Science ®Google Scholar
• Horvitz-Lennonn M, Iyer E, Minoletti A. Do low- and middle-income countries learn from the experience of high-income countries? Lessons from the use of atypical antipsychotics for treatment of schizophrenia. Int J Mental Health. 2013;42(1):33–50.
   Google Scholar
• Wagenaar BH, Stergachis A, Rao D, et al. The availability of essential medicines for mental healthcare in Sofala, Mozambique. Glob Health Action. 2015;8(1):27942.
   PubMed Web of Science ®Google Scholar